CVS Health set in motion a plan to close approximately 900 retail stores between 2022 and 2024, cutting roughly 300 locations per year while also trimming 2,900 corporate positions. The restructuring represents one of the largest pharmacy footprint reductions in the United States during a period when nearly 30 percent of all drugstores have disappeared. For millions of customers who rely on neighborhood pharmacies for prescriptions, vaccinations, and basic health services, the shrinking store count raises direct questions about access and convenience.
Why 300 annual CVS closures reshape pharmacy access
The scale of the CVS pullback is not a one-time correction. The company disclosed in its fourth-quarter 2021 earnings release that it would shut about 900 locations over three years, averaging roughly 300 closures per year. CVS tied the plan to its omnichannel strategy and a shift toward new store formats designed around health services rather than traditional retail aisles. The company also recorded impairment charges connected to the closure timeline, signaling that the financial hit was already baked into its books and that executives were prepared to live with near-term pain in exchange for longer-term strategic flexibility.
The closures land in a market that has been losing pharmacies at an alarming rate. Research cited by Associated Press reporting found that nearly 30 percent of U.S. drugstores shut down over a single decade. That wave has already created so-called pharmacy deserts in rural counties and lower-income urban neighborhoods where residents have few alternatives. When a chain as large as CVS removes 300 locations in a single year, the downstream effects on prescription filling, chronic disease management, and immunization rates can be immediate and measurable, especially in areas where independent pharmacies have already disappeared.
A reasonable hypothesis is that as brick-and-mortar locations close, prescription volume will migrate to CVS’s mail-order pharmacy and digital platforms. If that shift happens smoothly, quarterly script counts at those channels should rise within 18 months of each closure wave, potentially offsetting declines at shuttered sites. Regional closure maps overlaid with mail-order enrollment data and telehealth usage would offer a direct test of whether CVS is successfully retaining customers or simply watching them drift to competitors. The risk is that patients who are older, lack broadband access, or need same-day medications will not make that transition easily, leaving gaps that no app can fill and forcing some to delay or skip treatment.
Store-format strategy and impairment charges behind the cuts
CVS did not frame the closures as a retreat. The company described the plan as part of a broader repositioning that includes converting some remaining stores into health hubs offering primary care, mental health counseling, and diagnostic services. The omnichannel label covers everything from curbside pickup and same-day delivery to expanded telehealth integration and more robust digital prescription management. By shedding underperforming locations, CVS aimed to redirect capital toward these higher-margin formats and to markets where its retail presence can be tightly integrated with insurance and care-delivery businesses.
The impairment charges tied to the 2022–2024 closure plan reflect the cost of breaking leases, writing down fixtures, and absorbing severance. These non-cash and cash expenses effectively acknowledge that certain stores will never generate enough profit to justify their remaining lease lives or capitalized build-out costs. Combined with 2,900 corporate job cuts, the restructuring signals a company betting that a leaner physical presence paired with digital tools will produce better returns than maintaining a sprawling store network built for a different era of retail pharmacy. Investors tend to reward such discipline, but the accounting reality is that communities often feel the impact long before any efficiency gains show up in earnings per share.
The corporate layoffs, while less visible to customers than boarded-up storefronts, are central to the same cost-reduction story. Eliminating thousands of back-office roles in areas such as store support, marketing, and administration lowers ongoing overhead and helps fund investments in technology, analytics, and clinical services. Yet fewer corporate staff can also mean less localized support for individual pharmacies navigating staffing shortages, supply disruptions, or community health crises. For front-line pharmacists and technicians already stretched thin, the combination of leaner headquarters support and rising clinical expectations may translate into heavier workloads and longer wait times for patients.
For regulators and public health officials, the CVS retrenchment underscores a broader policy dilemma: how to encourage innovation in pharmacy care without deepening access gaps in vulnerable communities. State boards of pharmacy, Medicaid programs, and local health departments may need to track closure patterns more closely and consider incentives for new providers to enter areas left behind. Community-based solutions-from mobile clinics to partnerships with independent pharmacies and health centers-will likely play a larger role as large chains concentrate on fewer, more profitable sites.
Ultimately, the wave of CVS closures illustrates a structural shift rather than a temporary blip. As the company leans into digital tools and health-focused formats, the traditional corner drugstore is giving way to a more segmented model in which some locations become comprehensive care hubs while others vanish entirely. Whether that evolution improves or undermines patient outcomes will depend on how well the new system serves those least able to navigate change: older adults, people with chronic illnesses, and residents of communities that already sit at the edge of the health-care map.
David M. Keller is a finance writer based in Columbus, Ohio, covering personal finance and consumer-focused economic topics. He earned his degree in journalism from Ohio University and began his career reporting on local business and economic trends for a regional media outlet. Since then, he has contributed to a variety of online publications, focusing on clear, practical coverage of topics such as cost of living, debt, and everyday financial decision-making.
